For instance, a reduction in glutamate uptake and in the expression of glutamate transporter-1 (GLT1) and glutamate/aspartate transporter (GLAST) in the nigrostriatal pathway have been described in different PD rodent models [122,123,124]. This evidence concerns the gene SLC1A2 and Parkinson disease.